Free Trial

Century Therapeutics (IPSC) 10K Form and Latest SEC Filings 2026

Century Therapeutics logo
$2.31 -0.03 (-1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$2.31 0.00 (-0.22%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Century Therapeutics SEC Filings & Recent Activity

Century Therapeutics (NASDAQ:IPSC) has submitted 265+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 4 submitted on May 6, 2026.

Form 4
Century Therapeutics, Inc. Reports Ownership Change on May. 6, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Century Therapeutics Files Current Report on Mar. 26, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Century Therapeutics Files Annual Report on Mar. 12, 2026

The 10-K contains Century Therapeutics's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Century Therapeutics SEC Filing History

Browse Century Therapeutics' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/06/2026 4:27 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 3:54 PM
Century Therapeutics (1850119) Filer
Form DEFA14A
04/27/2026 3:49 PM
Century Therapeutics (1850119) Filer
Form DEF 14A
04/16/2026 3:14 PM
Century Therapeutics (1850119) Filer
Form ARS
04/10/2026 4:02 PM
Century Therapeutics (1850119) Issuer
Murphy Martin Patrick (2127581) Reporting
Form 3
Initial statement of beneficial ownership of securities  
04/10/2026 4:07 PM
Century Therapeutics (1850119) Issuer
Murphy Martin Patrick (2127581) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 6:18 PM
Century Therapeutics (1850119) Issuer
Cowan Chad (2039294) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2026 3:40 PM
Century Therapeutics (1850119) Filer
Form 424B5
03/26/2026 3:42 PM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2026 3:03 PM
Century Therapeutics (1850119) Issuer
Russotti Gregory (1867305) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 3:04 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:05 PM
Century Therapeutics (1850119) Issuer
Cowan Chad (2039294) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:07 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:23 PM
Century Therapeutics (1850119) Subject
Russotti Gregory (1867305) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2026 7:27 AM
Century Therapeutics (1850119) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2026 7:04 AM
Century Therapeutics (1850119) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2026 7:05 AM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2026 6:53 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2026 2:15 PM
Century Therapeutics (1850119) Subject
Russotti Gregory (1867305) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2026 4:12 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 11:15 PM
Century Therapeutics (1850119) Filer
Form EFFECT
02/05/2026 3:14 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2026 3:12 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2026 3:15 PM
Century Therapeutics (1850119) Issuer
Cowan Chad (2039294) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 3:05 PM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2026 3:32 PM
Century Therapeutics (1850119) Subject
Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by
Form SCHEDULE 13G
01/16/2026 3:34 PM
Century Therapeutics (1850119) Subject
RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by
Form SCHEDULE 13G
01/16/2026 3:23 PM
Century Therapeutics (1850119) Subject
Commodore Capital LP (1831942) Filed by
Form SCHEDULE 13G
01/15/2026 3:13 PM
Century Therapeutics (1850119) Subject
Deep Track Capital, LP (1856083) Filed by
Form SCHEDULE 13G
01/12/2026 8:05 AM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2026 11:15 PM
Century Therapeutics (1850119) Filer
Form EFFECT
01/08/2026 7:05 AM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2026 4:11 PM
Century Therapeutics (1850119) Filer
Form S-3/A
12/29/2025 3:52 PM
Century Therapeutics (1850119) Issuer
Cowan Chad (2039294) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 5:38 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 3:16 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 3:08 PM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 5:04 PM
Century Therapeutics (1850119) Issuer
Lee Han Myung (2100154) Reporting
Form 3
Initial statement of beneficial ownership of securities  
12/11/2025 5:04 PM
Century Therapeutics (1850119) Issuer
Lee Han Myung (2100154) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 3:34 PM
Century Therapeutics (1850119) Issuer
Russotti Gregory (1867305) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 3:34 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 3:58 PM
Century Therapeutics (1850119) Subject
Pfeiffenberger Brent (2001162) Reporting
Form 144/A
12/09/2025 7:05 AM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2025 2:29 PM
Century Therapeutics (1850119) Subject
Pfeiffenberger Brent (2001162) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2025 2:17 PM
Century Therapeutics (1850119) Subject
Russotti Gregory (1867305) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2025 3:06 PM
Century Therapeutics (1850119) Filer
Form DEFA14A
11/21/2025 3:05 PM
Century Therapeutics (1850119) Filer
Form PRE 14A
11/20/2025 5:02 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 2:15 PM
Century Therapeutics (1850119) Subject
Cowan Chad (2039294) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:19 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2025 3:16 PM
Century Therapeutics (1850119) Subject
Pfeiffenberger Brent (2001162) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2025 6:52 AM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2025 6:35 AM
Century Therapeutics (1850119) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/22/2025 3:56 PM
Century Therapeutics (1850119) Issuer
Cowan Chad (2039294) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:28 PM
Century Therapeutics (1850119) Issuer
Russotti Gregory (1867305) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:29 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:34 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025 3:10 PM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025 3:12 PM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025 5:23 PM
Century Therapeutics (1850119) Issuer
Walbert Timothy P (1349376) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:23 PM
BUTITTA CYNTHIA M (1222082) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:24 PM
Century Therapeutics (1850119) Issuer
Quimi Daphne (1543031) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:25 PM
Carlo Rizzuto (1817033) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:25 PM
Century Therapeutics (1850119) Issuer
Riva Alessandro (1867172) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:26 PM
Century Therapeutics (1850119) Issuer
JIMENEZ JOSEPH (1199095) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:26 PM
Blackwell Kimberly (1816465) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 4:10 PM
Century Therapeutics (1850119) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025 4:04 PM
Century Therapeutics (1850119) Issuer
Russotti Gregory (1867305) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025 4:05 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025 4:05 PM
Century Therapeutics (1850119) Issuer
Farid Adrienne (1867310) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025 4:05 PM
Carr Douglas (1867173) Reporting
Century Therapeutics (1850119) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025 2:09 PM
Century Therapeutics (1850119) Subject
Russotti Gregory (1867305) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025 2:13 PM
Century Therapeutics (1850119) Subject
Farid Adrienne (1867310) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025 2:15 PM
Century Therapeutics (1850119) Subject
Pfeiffenberger Brent (2001162) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025 3:19 PM
Century Therapeutics (1850119) Issuer
Pfeiffenberger Brent (2001162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 2:47 PM
Century Therapeutics (1850119) Subject
Pfeiffenberger Brent (2001162) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Century Therapeutics SEC Filings - Frequently Asked Questions

Century Therapeutics (IPSC) has submitted 265+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

Century Therapeutics's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 4 submitted on May 6, 2026. This was an insider ownership change filed by 4 - Century Therapeutics, Inc. (0001850119) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:IPSC) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners